Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

References

• Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):1–10. doi:10.1016/0140-6736(90)90287-f.
   PubMed Web of Science ®Google Scholar
• Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–1920; quiz 1943. doi:10.1111/j.1572-0241.2006.00630.x.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, O’Neil J, Fass R. Update on functional heartburn. Gastroenterol Hepatol (N Y). 2017;13(12):725–734.
   PubMedGoogle Scholar
• Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a kalixanda study report. Scand J Gastroenterol. 2005;40(3):275–285. doi:10.1080/00365520510011579.
   PubMed Web of Science ®Google Scholar
• Gindea C, Birla R, Hoara P, et al. Barrett esophagus: history, definition and etiopathogeny. J Med Life. 2014;7(3):23–30.
   PubMedGoogle Scholar
• Zagari RM, Law GR, Fuccio L, et al. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol. 2010;105(3):565–571. doi:10.1038/ajg.2009.706.
   PubMed Web of Science ®Google Scholar
• Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut. 2005;54 (Suppl 1):i1–5. doi:10.1136/gut.2004.041517.
   PubMedGoogle Scholar
• Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–717. doi:10.1136/gut.2004.051821.
   PubMed Web of Science ®Google Scholar
• Andreasson A, Talley NJ, Walker MM, et al. An increasing incidence of upper gastrointestinal disorders over 23 years: a prospective population-based study in Sweden. Am J Gastroenterol. 2021;116(1):210–213. doi:10.14309/ajg.0000000000000972.
   PubMed Web of Science ®Google Scholar
• Agreus L, Hellstrom PM, Talley NJ, et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United European Gastroenterol J. 2016;4(5):686–696.
   PubMed Web of Science ®Google Scholar
• Khan Z, Alastal Y, Khan MA, et al. On-demand therapy with proton pump inhibitors for maintenance treatment of nonerosive reflux disease or mild erosive esophagitis: a systematic review and Meta-Analysis. Gastroenterol Res Pract. 2018;2018:6417526–6417510. doi:10.1155/2018/6417526.
   PubMed Web of Science ®Google Scholar
• Yu LY, Sun LN, Zhang XH, et al. A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther. 2017;34(5):1070–1086. doi:10.1007/s12325-017-0532-9.
   PubMed Web of Science ®Google Scholar
• Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018;12(1):7–16. doi:10.5009/gnl16615.
   PubMed Web of Science ®Google Scholar
• DeSalvo KB, Fan VS, McDonell MB, et al. Predicting mortality and healthcare utilization with a single question. Health Serv Res. 2005;40(4):1234–1246. doi:10.1111/j.1475-6773.2005.00404.x.
   PubMed Web of Science ®Google Scholar
• DeSalvo KB, Bloser N, Reynolds K, et al. Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med. 2006;21(3):267–275. doi:10.1111/j.1525-1497.2005.00291.x.
   PubMed Web of Science ®Google Scholar
• Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav. 1997;38(1):21–37.
   PubMed Web of Science ®Google Scholar
• Mastellos N, Blizniuk G, Czopnik D, et al. Feasibility and acceptability of TRANSFoRm to improve clinical trial recruitment in primary care. Fam Pract. 2016;33(2):186–191.
   PubMed Web of Science ®Google Scholar
• Ethier JF, Curcin V, McGilchrist MM, et al. eSource for clinical trials: implementation and evaluation of a standards-based approach in a real world trial. Int J Med Inform. 2017;106:17–24.
   PubMed Web of Science ®Google Scholar
• Lim SN, Keung C, Zhao L, et al. TRANSFoRm: implementing a learning healthcare system in Europe through embedding clinical research into clinical practice. 48th Hawaii International Conference on System Sciences IEEE; 2015.
   Google Scholar
• Saganowski S, Misiaszek A, Brodka P, et al. TRANSFoRm eHealth solution for quality of life monitoring. AMIA Jt Summits Transl Sci Proc. 2016;2016:231–239.
   PubMedGoogle Scholar
• Jankowski J, Saganowski S, Bródka P. Evaluation of TRANSFoRm mobile eHealth solution for remote patient monitoring during clinical trials. Mobile Inform Syst. 2016;2016:1–16. doi:10.1155/2016/1029368.
   Web of Science ®Google Scholar
• Mastellos N, Andreasson A, Huckvale K, et al. A cluster randomised controlled trial evaluating the effectiveness of eHealth-supported patient recruitment in primary care research: the TRANSFoRm study protocol. Implement Sci. 2015;10(15).
   PubMedGoogle Scholar
• Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(1):52–57.
   PubMed Web of Science ®Google Scholar
• Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–164. doi:10.1136/bmj.305.6846.160.
   PubMed Web of Science ®Google Scholar
• Ganna A, Ingelsson E. 5 Year mortality predictors in 498,103 UK biobank participants: a prospective population-based study. Lancet. 2015;386(9993):533–540. doi:10.1016/S0140-6736(15)60175-1.
   PubMed Web of Science ®Google Scholar
• Shek DT, Ma CM. Longitudinal data analyses using linear mixed models in SPSS: concepts, procedures and illustrations. Sci World J. 2011;11:42–76. doi:10.1100/tsw.2011.2.
   Web of Science ®Google Scholar
• Shaw M, Dent J, Beebe T, et al. The reflux disease questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes. 2008;6(1):31. doi:10.1186/1477-7525-6-31.
   PubMedGoogle Scholar
• El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut. 2007;56(6):749–755. doi:10.1136/gut.2006.100263.
   PubMed Web of Science ®Google Scholar
• Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3: CD011969.
   PubMedGoogle Scholar